These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Overexpression of p53 protein in basal cell carcinomas of human skin. Shea CR; McNutt NS; Volkenandt M; Lugo J; Prioleau PG; Albino AP Am J Pathol; 1992 Jul; 141(1):25-9. PubMed ID: 1632467 [TBL] [Abstract][Full Text] [Related]
23. Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms. Ulanet DB; Hanahan D PLoS One; 2010 Aug; 5(8):e12454. PubMed ID: 20805995 [TBL] [Abstract][Full Text] [Related]
24. Gain of function in the mouse model of a recurrent mutation p53 Zhao L; Wang B; Zhao X; Wu X; Zhang Q; Wei C; Shi M; Li Y; Tang W; Zhang J; Yang J; Singh SK; Jia S; Luo Y Mol Carcinog; 2018 Feb; 57(2):147-158. PubMed ID: 28949402 [TBL] [Abstract][Full Text] [Related]
25. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors. Kudchadkar R; Lewis K; Gonzalez R Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185 [TBL] [Abstract][Full Text] [Related]
26. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633 [TBL] [Abstract][Full Text] [Related]
27. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455 [TBL] [Abstract][Full Text] [Related]
28. Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling. Saran A Future Oncol; 2010 Jun; 6(6):1003-14. PubMed ID: 20528237 [TBL] [Abstract][Full Text] [Related]
30. p53-Dependent and -independent functions of the Arf tumor suppressor. Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746 [TBL] [Abstract][Full Text] [Related]
31. p53 and p16 Azzopardi S; Pang S; Klimstra DS; Du YN Neoplasia; 2016 Oct; 18(10):610-617. PubMed ID: 27664376 [TBL] [Abstract][Full Text] [Related]
32. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331 [TBL] [Abstract][Full Text] [Related]
33. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer. Liu-Smith F; Jia J; Zheng Y Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688 [TBL] [Abstract][Full Text] [Related]
34. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948 [TBL] [Abstract][Full Text] [Related]
35. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation. Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538 [TBL] [Abstract][Full Text] [Related]
36. Molecular biology of basal and squamous cell carcinomas. Emmert S; Schön MP; Haenssle HA Adv Exp Med Biol; 2014; 810():234-52. PubMed ID: 25207369 [TBL] [Abstract][Full Text] [Related]
37. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition. Macdonald FH; Yao D; Quinn JA; Greenhalgh DA Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529 [TBL] [Abstract][Full Text] [Related]
38. INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma. Yang N; Leung EL; Liu C; Li L; Eguether T; Jun Yao XJ; Jones EC; Norris DA; Liu A; Clark RA; Roop DR; Pazour GJ; Shroyer KR; Chen J Oncogene; 2017 Aug; 36(35):4997-5005. PubMed ID: 28459465 [TBL] [Abstract][Full Text] [Related]
39. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma. Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149 [TBL] [Abstract][Full Text] [Related]
40. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis. Volk EL; Fan L; Schuster K; Rehg JE; Harris LC Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]